Skip to main content

UPS Surpasses One Billion Covid-19 Vaccine Delivery Milestone, Continues To Deliver Hope Around The World

COVID-19 vaccines delivered with 99.9 percent on-time performance to more than 110 countries to support the ongoing fight against the global pandemic

ATLANTA, Dec. 14, 2021 (GLOBE NEWSWIRE) — UPS (NYSE: UPS) today announced that it surpassed the one billion COVID-19 vaccine doses delivered mark with near-perfect on-time delivery. Just one year after the first vaccine was delivered by UPS, this milestone was made possible through UPS’s innovative approaches, one-of-a-kind UPS® Premier tracking technologies, industry-leading cold chain solutions, and an expansive, sophisticated, global network providing UPS Healthcare services to customers and communities around the world.

“UPSers have been essential in the fight against COVID-19, delivering equitable access to critical healthcare services’” said Chief Sales and Solutions Officer and Executive Vice President, UPS Global Healthcare Kate Gutmann. “This milestone would not have been possible without every person in our global network working tirelessly, alongside our partners and customers, to accelerate vaccine distribution and help keep communities as safe as possible.”

The global UPS network and dedicated UPS employees not only supported healthcare customers and global organizations, but also joined in public-private partnerships to provide vaccines and cold chain expertise to countries with hard-to-reach populations, ensuring delivery to as many people as possible. To achieve this, UPS Healthcare mapped roughly 500 trade lanes to enable seamless worldwide vaccine shipments and used more than three million pounds of dry ice to help safely move vaccines.

“UPS Healthcare has set the global pace for COVID-19 vaccine delivery, supported by the unmatched dedication of UPSers and the company’s global logistics capabilities and expertise,” said UPS Healthcare President Wes Wheeler. “Medicines derived from biologics and delivered via cutting edge cold chain networks represent the future of healthcare, and UPS Healthcare is leading the way.”

Unique examples of these global efforts include:

  • Ultra-cold freezer donations and in-kind vaccine deliveries to facilitate equitable distribution to remote and rural areas throughout Africa, South America, Asia, North America, and Europe, made possible by The UPS Foundation.
  • Three Regional 24/7 UPS Healthcare Command Centers, dedicated to predicting and managing the global vaccine movement to ensure on-time delivery, with contingency plans and solutions to mitigate the risks of extreme weather and other obstacles
  • Partnering with Gavi and other organizations to train and manage ultra-cold vaccine movement in COVAX countries, supporting COVID relief and healthcare infrastructure moving forward
  • Delivery of COVID-19 vaccines outside of the U.S. managing 4,500 movements through the UPS network and commercial partners since the first vaccines were made available. These flights, coordinated by UPS Global Freight Forwarding, add capacity to the already extensive UPS Airlines network and provide customers with even greater worldwide reach at a time when equitable vaccine distribution is key to global health.
  • Embedded UPS logistic experts in countries including Indonesia and Malawi to fully and safely manage vaccine distribution logistics
  • UPS support of vaccine doses delivered via autonomous aircraft to clinics in Africa through the partnership between Zipline and Gavi.
  • Real-time visibility into the location of vaccines through UPS® Premier technology, which provides precise visibility into every single vaccine package – down to within 10 feet of its location anywhere in the UPS global network
  • Supported over 130 vaccine clinical trials to date through the UPS Healthcare subsidiary Marken, which is involved in nearly all vaccines and treatments in development today.

“Service is in our DNA. We will continue to provide life-saving supplies, vaccines and other therapies with a constant eye on equitable distribution in every country we serve,” said Chief Corporate Affairs Officer Laura Lane, who also has responsibility for global social impact and sustainability.

Learn more about UPS’s global vaccine distribution and watch the video titled “Faces of One Billion” at About.UPS.com.  

About UPS
UPS (NYSE: UPS) is one of the world’s largest companies, with 2020 revenue of $84.6 billion, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories. Focused on its purpose statement, “Moving our world forward by delivering what matters,” the company’s more than 540,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. UPS also takes an unwavering stance in support of diversity, equality, and inclusion.  More information can be found at www.ups.comabout.ups.com and www.investors.ups.com.

CONTACT: UPS Media Relations
pr@ups.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.